HIGH DOSE SIMVASTATIN AS A POTENTIAL ANTICANCER THERAPY IN LEUKEMIA PATIENTS
Simvastatin is a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that is used for the treatment of hyperlipidemia. Simvastatin has recently been studied for its potential use in cancer therapy. In-vitro studies have shown that simvastatin displays anticancer activity, but at conc...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
UKnowledge
2013
|
| Subjects: | |
| Online Access: | http://uknowledge.uky.edu/pharmacy_etds/13 http://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1012&context=pharmacy_etds |